ID   Hep3BLAP-II
AC   CVCL_DI40
DR   Wikidata; Q54882808
RX   PubMed=21145827;
CC   Population: African American.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1834; CEBPB (Note=Isoform LAP).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
RX   PubMed=21145827; DOI=10.1016/j.jhep.2010.09.021;
RA   Saint-Auret, Gaelle
RA   Danan, Jean-Louis
RA   Hiron, Martine
RA   Blache, Celine
RA   Sulpice, Eric
RA   Tendil, Simon
RA   Daveau, Maryvonne
RA   Gidrol, Xavier
RA   Salier, Jean-Philippe
RT   "Characterization of the transcriptional signature of C/EBPbeta
RT   isoforms (LAP/LIP) in Hep3B cells: implication of LIP in pro-survival
RT   functions.";
RL   J. Hepatol. 54:1185-1194(2011).
//